Insider Activity Spotlight: Lionsgate Studios Corp.

Mark Rachesky’s Strategic Sell‑Off and the CV Transaction

On July 8, 2026, Mark Rachesky, M.D.—the physician‑turned‑investor who has maintained a sizable holding in Lionsgate through a network of affiliated entities—sold 1,469,450 shares of common stock. The transaction was executed at the market price of $13.47, a price virtually unchanged from the previous close ($13.49), and it was part of a broader “CV Transaction” involving multiple institutional partners. This sell‑off, while significant in volume, does not represent a break‑of‑trust event; rather, it appears to be a liquidity move within a larger structured swap that converts shares into limited partnership interests in several newly formed “Holdco” vehicles.

The CV Transaction is a continuation of the same swap that began in late‑June, whereby institutional partners contributed their holdings in exchange for equity in the new vehicles and in return received a share of future dividends and capital gains. Rachesky’s indirect pecuniary interest in the transaction was deemed to have increased, as the footnotes indicate that he is a managing member of the trust that holds the limited partnership stakes. Consequently, the sell‑off is likely a cash‑in for Rachesky’s personal portfolio while retaining exposure to Lionsgate’s underlying value through the Holdco structure.

What This Means for Investors

For long‑term investors, the transaction signals that Rachesky is comfortable with a partial liquidation of his position while still betting on Lionsgate’s growth trajectory. The lack of a significant price impact—given the flat change and the market’s overall 6.39 % weekly decline—suggests that the market has already priced in the move. Nonetheless, the transaction underscores the importance of monitoring how institutional investors structure their holdings. The use of Holdco entities can create a layer of complexity that may affect liquidity and dividend distribution. Investors should watch for any future disclosures on Holdco performance, especially as Lionsgate pushes into new consumer‑engagement initiatives like the Spin Master horror‑card game partnership.

Rachesky’s Historical Trading Pattern

Rachesky’s trading record over the past year reflects a cautious, long‑term approach. His most recent purchases (e.g., 7,983 shares on April 1 for $9.52 and 20,107 shares on November 28 for $7.46) occurred at discount levels relative to the July price, indicating a value‑buying stance. The bulk of his holdings—over 25 million shares across various entities—are held in restricted and restricted‑unit structures, suggesting a focus on long‑term capital appreciation and tax efficiency. His selling activity is sparse and typically aligns with corporate events (e.g., the CV Transaction) rather than market volatility. This pattern conveys a patient, institutional style that is not prone to short‑term speculation.

Company‑Wide Insider Movements

While Rachesky’s action is notable, Lionsgate’s broader insider activity remains relatively stable. CEO Jon Feltheimer and CFO James Barge have been trading in small blocks, alternating between buys and sells that keep their stake steady. These trades do not signal any erosion of confidence; instead, they reflect routine portfolio rebalancing. The most significant sell, by Feltheimer on July 3 for 103,669 shares, coincided with the same CV Transaction, reinforcing the idea that the underlying corporate structure is the primary catalyst rather than a change in management sentiment.

Strategic Outlook for Lionsgate

Lionsgate’s recent announcement of a partnership with Spin Master to develop a horror‑based trading‑card game highlights the studio’s push into physical‑digital hybrid products—a trend that could diversify revenue streams and deepen fan engagement. The company’s 52‑week high of $16.70 and a yearly gain of nearly 98 % attest to a robust growth trajectory, despite a current 6.39 % weekly slide. The market cap of roughly $3.9 billion positions Lionsgate as a mid‑cap player with significant upside potential if it can monetize its intellectual property across new channels.

In sum, Rachesky’s July 8 sell‑off is best viewed as a liquidity event within a larger structural transaction. For investors, the key signals are the continued institutional commitment to Lionsgate and the company’s strategic diversification into consumer‑engagement products. Monitoring future Holdco performance and any further insider transactions will be essential to gauge whether this restructuring translates into tangible value for shareholders.

DateOwnerTransaction TypeSharesPrice per ShareSecurity
N/ARACHESKY MARK H MD ()Holding262,212.00N/ACommon Shares
N/ARACHESKY MARK H MD ()Holding20,107.00N/ACommon Shares
N/ARACHESKY MARK H MD ()Holding2,385,199.00N/ACommon Shares
N/ARACHESKY MARK H MD ()Holding310,381.00N/ACommon Shares
N/ARACHESKY MARK H MD ()Holding4,607,598.00N/ACommon Shares
2026-07-08RACHESKY MARK H MD ()Sell1,469,450.00N/ACommon Shares
2026-07-08RACHESKY MARK H MD ()Sell3,701,988.00N/ACommon Shares
2026-07-08RACHESKY MARK H MD ()Sell25,173,882.00N/ACommon Shares
2026-07-08RACHESKY MARK H MD ()Buy797,526.00N/ACommon Shares
2026-07-08RACHESKY MARK H MD ()Buy1,916,271.00N/ACommon Shares
2026-07-08RACHESKY MARK H MD ()Buy11,154,680.00N/ACommon Shares
2026-07-08RACHESKY MARK H MD ()Buy671,924.00N/ACommon Shares
2026-07-08RACHESKY MARK H MD ()Sell499,765.00N/ACommon Shares
2026-07-08RACHESKY MARK H MD ()Buy499,765.00N/ACommon Shares
2026-07-08RACHESKY MARK H MD ()Buy15,804,919.00N/ACommon Shares
2026-07-08RACHESKY MARK H MD ()Sell11,755,412.00N/ACommon Shares
2026-07-08RACHESKY MARK H MD ()Buy11,755,412.00N/ACommon Shares